AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vaccine protects against aspergillosis.

Vaccine Weekly

| November 27, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A vaccine containing a sonicated preparation of Aspergillus fumigatus protected mice against invasive pulmonary aspergillosis, according to a research group in California.

"Invasive pulmonary aspergillosis is an emerging devastating infection in the immunocompromised host that is treated with corticosteroids for neoplastic disease or for organ transplantation," explained James I. Ito and Joseph M. Lyons at the City of Hope National Medical Center in Duarte, California.

The investigators used corticosteroid-treated CF-1 mice to test the protective effects of prior infection and two different vaccine preparations against a potentially lethal dose of A. fumigatus. One vaccine was a sonicated preparation of A. fumigatus and the other was an A. fumigatus filtrate preparation. Vaccines were delivered either intranasally or subcutaneously (Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. Journal of Infectious Diseases, 2002;186(6):869-871).

All of the control mice died after A. fumigatus challenge. In contrast, none of the mice that received the sonicate vaccine subcutaneously died. Prior infection resulted in 12.5% mortality, intranasal sonicate preparation 29%, subcutaneous filtrate preparation 50%, and intranasal filtrate vaccine 75%.

...

Related articles from newspapers, magazines, journals, and more
Invasive pulmonary Aspergillosis in a neonate treated successfully.
Newspaper article from: Biotech Business Week December 27, 2004 700+ words
...com & NewsRx.net) -- Invasive pulmonary Aspergillosis in a neonate was treated...and itraconazole. "A rare case of invasive pulmonary aspergillosis in a 1-month-old...aware, this is the first case of invasive pulmonary aspergillosis in a neonate with combined...
Antibacterials/antineoplastics: Invasive pulmonary aspergillosis and...
Magazine article from: Reactions Weekly Anonymous August 2, 2008 700+ words
...boys, aged 15 and 16 years, developed combined invasive pulmonary aspergillosis and hepatosplenic candidiasis during...Repeat chest CT scan findings were consistent with invasive pulmonary aspergillosis. Abdominal CT scan was indicative...
Novel murine model of invasive pulmonary aspergillosis developed.
Newspaper article from: Respiratory Therapeutics Week August 2, 2004 700+ words
...colleagues published their research in Antimicrobial Agents and Chemotherapy (Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother, 2004;48(5):1908-1911). For additional information, contact...
Spiration, Inc. Announces European Launch of Minimally Invasive Pulmonary...
Press release article from: Business Wire October 8, 2008 700+ words
Air Leak Compassionate Use Case Studies Presented at Annual European Respiratory Society Congress REDMOND, Wash. & BERLIN -- Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, today announced that Olympus has
Olympus Medical Systems Corp. and Spiration, Inc. Sign Agreement to Market and...
Press release article from: Business Wire May 19, 2008 700+ words
Agreement with Healthcare Leader Represents Broadest Distribution Agreement in Europe for a Bronchoscopic Treatment for Emphysema REDMOND, Wash. & TOKYO -- Olympus Medical Systems Corp. and Spiration, Inc. announced today that the companies have signed a definitive agreement granting Olympus
Spiration, Inc. Signs Agreement with Olympus Medical Systems for Development...
Press release article from: Business Wire July 24, 2008 700+ words
Agreement with Healthcare Leader Represents First of Kind Intended to Bring Access to New Emphysema Treatment to Japan REDMOND, Wash. -- Spiration, Inc., a developer of novel medical devices designed to benefit patients with severe and chronic conditions of the lung, announced today that it has
National Medical Care acquired by investor group.
Press release article from: PR Newswire August 6, 1984 700+ words
...6 /PRNewswire/ -- National Medical Care, Inc. and W. R...jointly announced today that National Medical Care has entered into...for the acquisition of National Medical Care by an investor group...
National Medical Health Card Systems, Inc.
Reference information from: International Directory of Company Histories Covell, Jeffrey January 1, 2006 700+ words
National Medical Health Card Systems, Inc. 26 Harbor...Insurance Agencies and Brokerages National Medical Health Card Systems, Inc. helps...offer their employees or members. National Medical offers its services to health maintenance...
For more facts and information, see all results

Source: HighBeam Research, Vaccine protects against aspergillosis.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA